CD4 and infection: In the final multivariate models on liver steatosis, increased BMI, triglycerides, age, CD4 count at study enrollment, and prior infection remained associated with liver steatosis in the total population, whereas CD4 count at study enrollment and exposure to raltegravir remained associated with liver steatosis in lean PHIV (Supplementary Figure 5 and Supplementary Table 6).